发明名称 N-link hydroxamic acid derivatives useful as antibacterial agents
摘要 The present invention is directed to a new class of hydroxamic acid derivatives, their use as LpxC inhibitors, and more specifically their use to treat bacterial infections.
申请公布号 US9018384(B2) 申请公布日期 2015.04.28
申请号 US201414447788 申请日期 2014.07.31
申请人 Pfizer Inc. 发明人 Brown Matthew Frank;Che Ye;Marfat Anthony;Melnick Michael Joesph;Montgomery Justin Ian;Reilly Usa
分类号 A61K31/44;C07D401/00;C07D213/64;C07D401/04;C07D401/08;C07D401/10;C07D401/12;C07D405/04;C07D405/10;C07D409/04;C07D413/10;C07D413/12;C07D417/04;C07D417/10;C07D417/12;C07D211/86;C07D403/04;C07D401/14 主分类号 A61K31/44
代理机构 代理人 Wichtowski John A.
主权项 1. A compound of the formula: or a pharmaceutically acceptable salt thereof,whereinR1 is methyl;R2 is methyl;R3 is hydrogen;L is absent, or is selected from the group consisting of C1-C6 alkylene which may be optionally substituted, C2-C6 alkenylene, C2-C6 alkynylene, —(CH2)p—O—(CH2)n, and —(CH2)p—O—(CH2)z—O—(CH2)n—;n is an integer ranging from 0 to 4;p is an integer ranging from 0 to 4;q is an integer ranging from 0 to 6z is an integer ranging from 1 to 4;D is selected from the group consisting of: i) (C3-C10)cycloalkyl, optionally substituted, ii) (C6-C10)aryl, optionally substituted, iii) heteroaryl, optionally substituted, iv) heterocyclic, optionally substituted,T is absent, or is —S—(CH2)z—O—(CH2)n, —O—(CH2)z—S—(CH2)n, —(CH2)q—, —(CH2)n—C(O)—(CH2)p—, —(CH2)n—O—(CH2)p—, —(CH2)n—S—(CH2)p, S—C1-C6 alkylene which may be optionally substituted, —O—C1-C6 alkylene which may be optionally substituted, —O—(CH2)p—C(O)—(CH2)n—, —(CH2)p—C(O)—(CH2)q—O—(CH2)n—, —O—(CH2)z—O—(CH2)n—, —O—(CH2)z—O—(CH2)z—O—(CH2)n—, —S—(CH2)z—S—(CH2)n—, —(CH2)n—SH, or —(CH2)n—OH, and;G is absent, or is selected from the group consisting of: i) (C3-C10)cycloalkyl, optionally substituted; ii) (C6-C10)aryl optionally substituted; iii) heteroaryl, optionally substituted, and; iv) heterocyclic, optionally substituted.
地址 New York NY US